|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,056.64 |
3.28% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$62,745.00 |
2.98% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$52,720.77 |
2.50% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$49,984.56 |
2.37% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,130.00 |
2.24% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$46,696.58 |
2.22% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,448.48 |
2.16% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$45,494.40 |
2.16% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$45,292.23 |
2.15% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,108.72 |
2.14% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$45,108.99 |
2.14% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$45,105.08 |
2.14% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,222.56 |
2.10% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,178.29 |
2.10% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,943.83 |
2.09% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,086.65 |
2.09% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$43,187.32 |
2.05% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,183.96 |
2.05% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$42,822.47 |
2.03% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$42,289.97 |
2.01% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,326.68 |
2.01% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,970.55 |
1.99% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$41,813.45 |
1.99% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$41,592.48 |
1.98% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$41,343.02 |
1.96% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$40,900.16 |
1.94% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$40,553.00 |
1.93% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$40,159.44 |
1.91% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$39,949.24 |
1.90% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$40,019.88 |
1.90% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$39,833.11 |
1.89% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$39,374.76 |
1.87% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$39,225.12 |
1.86% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$38,874.60 |
1.85% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$39,047.75 |
1.85% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,611.83 |
1.83% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,542.40 |
1.83% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$38,145.35 |
1.81% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$37,616.13 |
1.79% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$37,381.18 |
1.78% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$37,262.40 |
1.77% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$37,045.86 |
1.76% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$36,749.09 |
1.75% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,755.88 |
1.75% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,754.59 |
1.75% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$36,692.33 |
1.74% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,416.74 |
1.73% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$36,488.13 |
1.73% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$32,996.72 |
1.57% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,041.37 |
1.43% |
| US Dollar |
$USD |
|
1,910 |
$1,909.76 |
0.09% |
| Danish Krone |
$DKK |
|
8,190 |
$1,276.14 |
0.06% |
| New Zealand Dollar |
$NZD |
|
430 |
$248.37 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|